Annual CFI
Summary
- Current Value
- As of today, BIO annual cash from investing is -$160.20M, down -892.76% on
- Historical Performance
- BIO annual cash from investing is up +79.91% over the past 3 years, and up +23.31% over the past 5 years
- All-Time High Comparison
- BIO annual cash from investing is currently -892.76% below its historical high of $20.21M set on
- 3-Year Low Comparison
- BIO annual cash from investing is +86.73% above its 3-year low of -$1.21B reached on an earlier date
- Sector Comparison
- BIO annual cash from investing is higher than 14.66% of companies in Healthcare sector
Cash From Investing Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Investing | -$160.20M | -892.8% | +79.9% | +23.3% | +8.9% | |
| Quarterly Cash From Investing | -$43.00M | +22.7% | +51.4% | -147.3% | +29.8% | |
| TTM Cash From Investing | -$186.04M | -223.8% | +89.2% | -160.8% | +0.5% | |
| Price | $325.50 | -5.2% | -22.3% | -46.8% | +208.5% | |
| Annual Cash From Operations | $454.60M | +21.3% | +209.4% | -0.7% | +39.9% | |
| Annual Cash From Financing | -$218.20M | +48.7% | -293.7% | -858.8% | -174.2% | |
| Annual CAPEX | $165.60M | +5.7% | +23.8% | +68.1% | +116.9% | |
| Annual Free Cash Flow | $289.00M | +32.4% | +152.6% | -19.6% | +16.2% | |
| Annual Total Assets | $9.36B | -23.9% | -47.4% | +16.9% | +269.3% |
Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $20.21M | -892.8% | |
| 5Y | $20.21M | -892.8% | |
| All | $20.21M | -892.8% |
Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$1.21B | N/A | +86.7% |
| 5Y | -$1.21B | +86.7% | |
| All | -$1.21B | +86.7% |
Cash From Investing History
FAQ
What is the current annual cash from investing of BIO?
As of today, BIO annual cash from investing is -$160.20M
What is 1-year change in BIO annual cash from investing?
BIO annual cash from investing is down -892.76% year-over-year
What is 3-year change in BIO annual cash from investing?
BIO annual cash from investing is up +79.91% over the past 3 years
How far is BIO annual cash from investing from its all-time high?
BIO annual cash from investing is currently -892.76% below its historical high of $20.21M set on December 31, 2023
How does BIO annual cash from investing rank versus sector peers?
BIO annual cash from investing is higher than 14.66% of companies in Healthcare sector
When is BIO next annual earnings release?
The next annual earnings release for BIO is on
Quarterly CFI
Summary
- Current Value
- As of today, BIO quarterly cash from investing is -$43.00M, up +62.74% on
- Historical Performance
- BIO quarterly cash from investing is up +22.71% year-over-year, and up +51.37% over the past 3 years
- All-Time High Comparison
- BIO quarterly cash from investing is currently -123.89% below its historical high of $179.99M set on
- 3-Year Low Comparison
- BIO quarterly cash from investing is +62.74% above its 3-year low of -$115.40M reached on
- Sector Comparison
- BIO quarterly cash from investing is higher than 14.26% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Investing | -$43.00M | +62.7% | +22.7% | +51.4% | -147.3% | |
| Annual Cash From Investing | -$160.20M | – | -892.8% | +79.9% | +23.3% | |
| TTM Cash From Investing | -$186.04M | +6.4% | -223.8% | +89.2% | -160.8% | |
| Price | $325.50 | +5.3% | -5.2% | -22.3% | -46.8% | |
| Quarterly Cash From Operations | $120.90M | +3.8% | -26.1% | +109.0% | +155.7% | |
| Quarterly Cash From Financing | -$52.50M | +61.5% | +45.3% | -498.5% | -10000.0% | |
| Quarterly CAPEX | $31.70M | -30.6% | -21.2% | +15.0% | +58.7% | |
| Quarterly Free Cash Flow | $89.20M | +26.0% | -27.7% | +106.5% | +137.6% | |
| Quarterly Total Assets | $9.70B | -5.1% | -8.6% | -19.6% | -19.3% |
Quarterly Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.90M | -1582.8% | |
| 3Y | $72.20M | -159.6% | |
| 5Y | $72.20M | -159.6% | |
| All | $179.99M | -123.9% |
Quarterly Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$115.40M | +62.7% | |
| 3Y | -$115.40M | +62.7% | |
| 5Y | -$916.14M | +95.3% | |
| All | -$916.14M | +95.3% |
Quarterly Cash From Investing History
FAQ
What is the current quarterly cash from investing of BIO?
As of today, BIO quarterly cash from investing is -$43.00M
What is BIO quarterly cash from investing most recent change?
BIO quarterly cash from investing was up +62.74% on September 30, 2025
What is 1-year change in BIO quarterly cash from investing?
BIO quarterly cash from investing is up +22.71% year-over-year
How far is BIO quarterly cash from investing from its all-time high?
BIO quarterly cash from investing is currently -123.89% below its historical high of $179.99M set on September 30, 2013
How does BIO quarterly cash from investing rank versus sector peers?
BIO quarterly cash from investing is higher than 14.26% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
TTM CFI
Summary
- Current Value
- As of today, BIO TTM cash from investing is -$186.04M, up +6.36% on
- Historical Performance
- BIO TTM cash from investing is down -223.79% year-over-year, and up +89.16% over the past 3 years
- All-Time High Comparison
- BIO TTM cash from investing is currently -362.04% below its historical high of $71.00M set on
- 3-Year Low Comparison
- BIO TTM cash from investing is +84.59% above its 3-year low of -$1.21B reached on an earlier date
- Sector Comparison
- BIO TTM cash from investing is higher than 11.53% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Investing | -$186.04M | +6.4% | -223.8% | +89.2% | -160.8% | |
| Annual Cash From Investing | -$160.20M | – | -892.8% | +79.9% | +23.3% | |
| Quarterly Cash From Investing | -$43.00M | +62.7% | +22.7% | +51.4% | -147.3% | |
| Price | $325.50 | +5.3% | -5.2% | -22.3% | -46.8% | |
| TTM Cash From Operations | $491.47M | -8.0% | +19.4% | +161.5% | +244.7% | |
| TTM Cash From Financing | -$312.77M | +12.2% | +20.3% | -129.4% | -195.2% | |
| TTM CAPEX | $154.71M | -5.2% | -6.2% | +15.3% | +90.1% | |
| TTM Free Cash Flow | $336.76M | -9.2% | +36.6% | +136.1% | +180.0% | |
| Quarterly Total Assets | $9.70B | -5.1% | -8.6% | -19.6% | -19.3% |
TTM Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$114.21M | -62.9% | |
| 3Y | $47.59M | -490.9% | |
| 5Y | $47.59M | -490.9% | |
| All | $71.00M | -362.0% |
TTM Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$198.68M | +6.4% | |
| 3Y | -$1.21B | N/A | +84.6% |
| 5Y | -$1.72B | +89.2% | |
| All | -$1.72B | +89.2% |
TTM Cash From Investing History
FAQ
What is the current TTM cash from investing of BIO?
As of today, BIO TTM cash from investing is -$186.04M
What is BIO TTM cash from investing most recent change?
BIO TTM cash from investing was up +6.36% on September 30, 2025
What is 1-year change in BIO TTM cash from investing?
BIO TTM cash from investing is down -223.79% year-over-year
How far is BIO TTM cash from investing from its all-time high?
BIO TTM cash from investing is currently -362.04% below its historical high of $71.00M set on March 31, 2014
How does BIO TTM cash from investing rank versus sector peers?
BIO TTM cash from investing is higher than 11.53% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
Cash From Investing Formula
Data Sources & References
- BIO Official Website www.bio-rad.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/12208/000001220825000077/0000012208-25-000077-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/12208/000001220825000007/0000012208-25-000007-index.htm
- BIO Profile on Yahoo Finance finance.yahoo.com/quote/BIO
- BIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bio
